東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cell culture engineering and technol...

Portner, Ralf.

FindBook

Google Book

Amazon

博客來

Cell culture engineering and technology = in appreciation to Professor Mohamed Al-Rubeai /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cell culture engineering and technology/ edited by Ralf Portner.
其他題名:	in appreciation to Professor Mohamed Al-Rubeai /
其他作者:	Portner, Ralf.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	1 online resource (x, 550 p.) :ill., digital ;24 cm.
內容註:	Biopharmaceuticals Produced from Cultivated Mammalian Cells -- Remote Control of Mammalian Therapeutic Designer Cells -- Next generation cell engineering using microRNAs -- An Omic's data-driven approach towards engineering mammalian cell factories and bioprocesses for biopharmaceutical production -- Redesigning spent media from cell culture bioprocess to feed new bacterial fermentations -- Monoclonal antibody glycoengineering for biopharmaceutical quality assurance -- Next-generation cell engineering platform for improving recombinant protein production in mammalian cells -- Manufacturing human pluripotent stem cells and differentiated progenitors -- Biomanufacturing of Mesenchymal Stromal Cell for Therapeutic Applications -- Process Design for hMSC Products in Stirred Tank Bioreactors -- Bio-production of Adeno-associated virus for gene therapy -- Scale-up (and scale-down) of CHO cell culture, with a focus on how to adjust the various culture parameters/setpoints across different systems from lab-scale to manufacturing-scale -- Intensified and Continuous mAb Production with Single-Use Systems -- Mathematical modelling of cell culture processes -- Model-assisted design concepts for mammalian cell culture processes -- Bioprocess monitoring and control -- Industrial Monitoring of Cell Culture.
Contained By:	Springer Nature eBook
標題:	Cell culture. -
電子資源:	https://doi.org/10.1007/978-3-030-79871-0
ISBN:	9783030798710

Cell culture engineering and technology = in appreciation to Professor Mohamed Al-Rubeai /
Cell culture engineering and technologyin appreciation to Professor Mohamed Al-Rubeai /[electronic resource] :edited by Ralf Portner. - Cham :Springer International Publishing :2021. - 1 online resource (x, 550 p.) :ill., digital ;24 cm. - Cell engineering ;v. 10. - Cell engineering ;v. 10..

Biopharmaceuticals Produced from Cultivated Mammalian Cells -- Remote Control of Mammalian Therapeutic Designer Cells -- Next generation cell engineering using microRNAs -- An Omic's data-driven approach towards engineering mammalian cell factories and bioprocesses for biopharmaceutical production -- Redesigning spent media from cell culture bioprocess to feed new bacterial fermentations -- Monoclonal antibody glycoengineering for biopharmaceutical quality assurance -- Next-generation cell engineering platform for improving recombinant protein production in mammalian cells -- Manufacturing human pluripotent stem cells and differentiated progenitors -- Biomanufacturing of Mesenchymal Stromal Cell for Therapeutic Applications -- Process Design for hMSC Products in Stirred Tank Bioreactors -- Bio-production of Adeno-associated virus for gene therapy -- Scale-up (and scale-down) of CHO cell culture, with a focus on how to adjust the various culture parameters/setpoints across different systems from lab-scale to manufacturing-scale -- Intensified and Continuous mAb Production with Single-Use Systems -- Mathematical modelling of cell culture processes -- Model-assisted design concepts for mammalian cell culture processes -- Bioprocess monitoring and control -- Industrial Monitoring of Cell Culture.

This contributed volume is dedicated towards the progress achieved within the last years in all areas of Cell Culture Engineering and Technology. It comprises contributions of active researchers in the field of cell culture development for the production of recombinant proteins, cell line development, cell therapy and gene therapy, with consideration of media development, process scale-up, reactor design, monitoring and control and model-assisted strategies for process design. The knowledge and expertise of the authors cover disciplines like cell biology, engineering, biotechnology and biomedical sciences. This book is conceived for graduate students, postdoctoral fellows and researchers interested in the latest developments in Cell Engineering.

ISBN: 9783030798710

Standard No.: 10.1007/978-3-030-79871-0doiSubjects--Topical Terms:

604671
Cell culture.

LC Class. No.: QH585.2 / C45 2021

Dewey Class. No.: 571.638

Cell culture engineering and technology = in appreciation to Professor Mohamed Al-Rubeai /
LDR:03155nmm a2200337 a 4500 001 2262258
003 DE-He213
005 20220220154414.0
006 m o d
007 cr nn 008maaau
008 220616s2021 sz s 0 eng d
020 $a 9783030798710 $q (electronic bk.)
020 $a 9783030798703 $q (paper)
024 7 $a 10.1007/978-3-030-79871-0 $2 doi
035 $a 978-3-030-79871-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QH585.2 $b C45 2021
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 571.638 $2 23
090 $a QH585.2 $b .C393 2021
245 0 0 $a Cell culture engineering and technology $h [electronic resource] : $b in appreciation to Professor Mohamed Al-Rubeai / $c edited by Ralf Portner.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a 1 online resource (x, 550 p.) : $b ill., digital ; $c 24 cm.
490 1 $a Cell engineering ; $v v. 10
505 0 $a Biopharmaceuticals Produced from Cultivated Mammalian Cells -- Remote Control of Mammalian Therapeutic Designer Cells -- Next generation cell engineering using microRNAs -- An Omic's data-driven approach towards engineering mammalian cell factories and bioprocesses for biopharmaceutical production -- Redesigning spent media from cell culture bioprocess to feed new bacterial fermentations -- Monoclonal antibody glycoengineering for biopharmaceutical quality assurance -- Next-generation cell engineering platform for improving recombinant protein production in mammalian cells -- Manufacturing human pluripotent stem cells and differentiated progenitors -- Biomanufacturing of Mesenchymal Stromal Cell for Therapeutic Applications -- Process Design for hMSC Products in Stirred Tank Bioreactors -- Bio-production of Adeno-associated virus for gene therapy -- Scale-up (and scale-down) of CHO cell culture, with a focus on how to adjust the various culture parameters/setpoints across different systems from lab-scale to manufacturing-scale -- Intensified and Continuous mAb Production with Single-Use Systems -- Mathematical modelling of cell culture processes -- Model-assisted design concepts for mammalian cell culture processes -- Bioprocess monitoring and control -- Industrial Monitoring of Cell Culture.
520 $a This contributed volume is dedicated towards the progress achieved within the last years in all areas of Cell Culture Engineering and Technology. It comprises contributions of active researchers in the field of cell culture development for the production of recombinant proteins, cell line development, cell therapy and gene therapy, with consideration of media development, process scale-up, reactor design, monitoring and control and model-assisted strategies for process design. The knowledge and expertise of the authors cover disciplines like cell biology, engineering, biotechnology and biomedical sciences. This book is conceived for graduate students, postdoctoral fellows and researchers interested in the latest developments in Cell Engineering.
650 0 $a Cell culture. $3 604671
650 0 $a Genetic engineering. $3 530509
650 1 4 $a Biomedical Research. $3 851895
650 2 4 $a Cell Biology. $3 892383
650 2 4 $a Biological Techniques. $3 900035
650 2 4 $a Regenerative Medicine and Tissue Engineering. $3 3538451
650 2 4 $a Biomedical Engineering and Bioengineering. $3 3381533
700 1 $a Portner, Ralf. $3 1002951
700 1 $a Al-Rubeai, Mohamed. $3 895150
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Cell engineering ; $v v. 10. $3 3538455
856 4 0 $u https://doi.org/10.1007/978-3-030-79871-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)